Saba Capital Management, L.P. bought HQL
May 30, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 669 shares of Abrdn Life Sciences Investors at $13.05 per share, a transaction worth $8.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
669
Price
$13.05
Total value
$8.7K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 30, 2024
Filing dateMay 31, 2024
Shares owned after3,299,299
OwnershipIndirect
10b5-1 planNo
AmendedNo